A 54-year-old man with obesity and type 2 diabetes has persistently elevated ALT and ultrasound evidence of hepatic steatosis. Viral hepatitis serology is negative and there is no history of significant alcohol intake. Fibrosis assessment suggests low fibrosis risk. What is the most appropriate first-line management strategy for his non-alcoholic fatty liver disease (NAFLD)?